• Five and ten-year strategic plans for stem cell research, including infrastructure and facilities;
  
  
• Seed grant program for campus researchers;
  
  
• Bioethical issues;
  
  
• Strategies for translating lab findings into clinical care;
  
  
• Reviewing and approving facilities needed for human embryonic stem cell research.

Advisory Group:

• Mark Zern, M.D. – Clinical research
  
  
• Alice Tarantal, Ph.D. – Translational research
  
  
• Gerhard Bauer – GMP facility
  
  
• Ann Bonham, Ph.D. – Executive Associate Dean, School of Medicine
  
  
• David Pleasure, M.D. – UC Davis-Shriner's Institute of Pediatric Regenerative Medicine, basic research
  
  
• Fred Meyers, M.D. – Stem cell training program
  
  
• Lars Bergland, Ph.D. – Clinical and Translational Science Center  
  
  
• Ted Wandzilak, Ph.D. – Facilities
  
  
• Simon Cherry, Ph.D. – In vivo imaging
  
  
• Lisa Ikemoto, J.D. – Bioethics